 LOS ANGELES, March 16, 2021 PRNewswire -- Glancy Prongay Murray LLP GPM reminds investors of the upcoming April 30, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Aquestive Therapeutics, Inc. Aquestive or the Company NASDAQ: AQST securities between December 2, 2019 and September 25, 2020 , inclusive the Class Period. If you suffered a loss on your Aquestive investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at 